LRRK2 and tuberculosis: The integrated GWAS, Hi-C, eQTL, ChIP-Seq, and ATAC-Seq analysis identify the long-range target genes of mycobacterial disease-susceptible SNPs and identify LRRK2 as a potential drug target, whose inhibitor AdoCbl has an anti-tuberculosis effect both in vitro and in vivo.